Vanguard Global Advisers’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
Other funds holding ARMP
GWM
Vanguard Global Advisers's ARMP Position: Q3 2026 in Review
Vanguard Global Advisers increased its Armata Pharmaceuticals (ARMP) stake by 1.5% in Q3 2026, buying an estimated $277 and bringing the position to 4,022 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3430.
Vanguard Global Advisers first reported a position in ARMP in Q1 2026 and has held it in 3 quarters since. The position peaked at $40.6K in Q1 2026. 64 funds tracked by Wall St. Rank hold ARMP as of Q3 2026.
- Vanguard Global Advisers held 4,022 shares of Armata Pharmaceuticals worth $14.8K as of Q3 2026.
- Vanguard Global Advisers bought 58 Armata Pharmaceuticals shares in Q3 2026, an estimated $277.
- Armata Pharmaceuticals made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3430 holding.
- Vanguard Global Advisers first reported a position in Armata Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's Armata Pharmaceuticals position peaked at $40.6K in Q1 2026.
- 64 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.